Comparison of Ivabradine and Beta-blockers Administration in the Treatment of Inappropriate Sinus Tachycardia
Phase of Trial: Phase III
Latest Information Update: 04 Oct 2016
Price : $35 *
At a glance
- Drugs Ivabradine (Primary) ; Bisoprolol
- Indications Sinus tachycardia
- Focus Therapeutic Use
- Acronyms CIBIST
- 29 Sep 2016 Status changed from recruiting to completed.
- 09 Nov 2015 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 04 Nov 2015 Planned End Date changed from 1 Dec 2014 to 1 Jun 2016 as per ClinicalTrials.gov record.